These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31131262)

  • 1. Immunomodulation From Moderate Exercise Promotes Control of Experimental Cutaneous Leishmaniasis.
    Terra R; Alves PJF; Lima AKC; Gomes SMR; Rodrigues LS; Salerno VP; Da-Silva SAG; Dutra PML
    Front Cell Infect Microbiol; 2019; 9():115. PubMed ID: 31131262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.
    Oghumu S; Stock JC; Varikuti S; Dong R; Terrazas C; Edwards JA; Rappleye CA; Holovatyk A; Sharpe A; Satoskar AR
    Infect Immun; 2015 Jan; 83(1):67-76. PubMed ID: 25312956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB/c mice.
    Zanganeh E; Soudi S; Zavaran Hosseini A; Khosrojerdi A
    Immunol Lett; 2019 Dec; 216():97-105. PubMed ID: 31622634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protective effect of a combined L5 plus L3 Leishmania major ribosomal protein based vaccine combined with a Th1 adjuvant in murine cutaneous and visceral leishmaniasis.
    Ramirez L; Corvo L; Duarte MC; Chávez-Fumagalli MA; Valadares DG; Santos DM; de Oliveira CI; Escutia MR; Alonso C; Bonay P; Tavares CA; Coelho EA; Soto M
    Parasit Vectors; 2014 Jan; 7():3. PubMed ID: 24382098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.
    Bretscher PA; Ogunremi O; Menon JN
    Behring Inst Mitt; 1997 Feb; (98):153-9. PubMed ID: 9382736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine.
    Schwarz T; Remer KA; Nahrendorf W; Masic A; Siewe L; Müller W; Roers A; Moll H
    PLoS Pathog; 2013; 9(6):e1003476. PubMed ID: 23825956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses.
    Nabors GS; Farrell JP
    Infect Immun; 1994 Dec; 62(12):5498-504. PubMed ID: 7960131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-gamma response and increased production of T helper 2 cytokines.
    Krishnan L; Guilbert LJ; Russell AS; Wegmann TG; Mosmann TR; Belosevic M
    J Immunol; 1996 Jan; 156(2):644-52. PubMed ID: 8543816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone.
    Li J; Nolan TJ; Farrell JP
    Exp Parasitol; 1997 Sep; 87(1):47-57. PubMed ID: 9287957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute IL-4 Governs Pathogenic T Cell Responses during
    Poudel B; Yorek MS; Mazgaeen L; Brown SA; Kanneganti TD; Gurung P
    Immunohorizons; 2020 Sep; 4(9):546-560. PubMed ID: 32948646
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis.
    Webb JR; Kaufmann D; Campos-Neto A; Reed SG
    J Immunol; 1996 Dec; 157(11):5034-41. PubMed ID: 8943412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic dietary protein guides maturation of the host immune system promoting resistance to Leishmania major infection in C57BL/6 mice.
    Amaral JF; Gomes-Santos AC; Paula-Silva J; Nicoli JR; Vieira LQ; Faria AM; Menezes JS
    Immunology; 2010 Mar; 129(3):455-64. PubMed ID: 20002788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania major H-line attenuated under pressure of gentamicin, induces a Th1 response which protects susceptible BALB/c mice against infection with virulent L. major.
    Daneshvar H; Burchmore R; Hagan P; Phillips RS
    Parasitology; 2009 Sep; 136(11):1243-50. PubMed ID: 19646303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ox40L-Ox40 pathway plays distinct roles in regulating Th2 responses but does not determine outcome of cutaneous leishmaniasis caused by Leishmania mexicana and Leishmania major.
    Tuladhar R; Oghumu S; Dong R; Peterson A; Sharpe AH; Satoskar AR
    Exp Parasitol; 2015 Jan; 148():49-55. PubMed ID: 25447125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-9 is a susceptibility factor in Leishmania major infection by promoting detrimental Th2/type 2 responses.
    Arendse B; Van Snick J; Brombacher F
    J Immunol; 2005 Feb; 174(4):2205-11. PubMed ID: 15699153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single intradermal administration of soluble leishmanial antigen and plasmid expressing interleukin-12 protects BALB/c mice from Leishmania major infection.
    Yamakami K; Akao S; Sato M; Nitta Y; Miyazaki J; Tadakuma T
    Parasitol Int; 2001 Jul; 50(2):81-91. PubMed ID: 11438430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.